StonvexLoading…
StonvexStonvexStonvexCore line items from CRWV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.08B | $5.13B | $3.56B | $2.19B |
Operating Income | $-144.00M | $-46.00M | $43.59M | $-8.26M |
Net Income | $-740.00M | $-1.17B | $-715.27M | $-290.51M |
EPS (Diluted) | $-1.40 | $-2.81 | $-1.87 | $-1.79 |
Total Assets | $55.57B | $49.30B | $32.91B | $26.24B |
Total Liabilities | $50.81B | $45.97B | $29.03B | $22.42B |
Cash & Equivalents | $2.24B | $3.13B | $1.89B | $1.15B |
Free Cash Flow OCF − CapEx | $-4.71B | $-7.25B | $-4.75B | $-4.05B |
Shares Outstanding | 527.00M | 436.00M | 412.18M | 368.61M |